Logo image of ACON

ACLARION INC (ACON) Stock Fundamental Analysis

NASDAQ:ACON - Nasdaq - US6551872012 - Common Stock

0.0425  +0 (+0.47%)

Premarket: 0.044 +0 (+3.53%)

Fundamental Rating

1

ACON gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 39 industry peers in the Health Care Technology industry. ACON has a bad profitability rating. Also its financial health evaluation is rather negative. ACON is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ACON had negative earnings in the past year.
ACON had a negative operating cash flow in the past year.
ACON Yearly Net Income VS EBIT VS OCF VS FCFACON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -2M -4M -6M

1.2 Ratios

The Return On Assets of ACON (-191.03%) is worse than 89.19% of its industry peers.
ACON has a worse Return On Equity (-359.30%) than 81.08% of its industry peers.
Industry RankSector Rank
ROA -191.03%
ROE -359.3%
ROIC N/A
ROA(3y)-257.22%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACON Yearly ROA, ROE, ROICACON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 500 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ACON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACON Yearly Profit, Operating, Gross MarginsACON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 -2K -4K -6K -8K -10K

More info and screens

2

2. Health

2.1 Basic Checks

ACON does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ACON has more shares outstanding
Compared to 1 year ago, ACON has a worse debt to assets ratio.
ACON Yearly Shares OutstandingACON Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M
ACON Yearly Total Debt VS Total AssetsACON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M

2.2 Solvency

ACON has an Altman-Z score of -26.38. This is a bad value and indicates that ACON is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ACON (-26.38) is worse than 91.89% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that ACON is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.47, ACON is not doing good in the industry: 64.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z -26.38
ROIC/WACCN/A
WACC8.57%
ACON Yearly LT Debt VS Equity VS FCFACON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M -2M -4M -6M

2.3 Liquidity

A Current Ratio of 1.28 indicates that ACON should not have too much problems paying its short term obligations.
ACON has a Current ratio (1.28) which is comparable to the rest of the industry.
ACON has a Quick Ratio of 1.28. This is a normal value and indicates that ACON is financially healthy and should not expect problems in meeting its short term obligations.
ACON's Quick ratio of 1.28 is in line compared to the rest of the industry. ACON outperforms 43.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.28
ACON Yearly Current Assets VS Current LiabilitesACON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 85.81% over the past year.
The Revenue for ACON has decreased by -35.17% in the past year. This is quite bad
The Revenue has been growing by 15.77% on average over the past years. This is quite good.
EPS 1Y (TTM)85.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.79%
Revenue 1Y (TTM)-35.17%
Revenue growth 3Y15.77%
Revenue growth 5YN/A
Sales Q2Q%-35.74%

3.2 Future

ACON is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.95% yearly.
Based on estimates for the next years, ACON will show a very negative growth in Revenue. The Revenue will decrease by -27.54% on average per year.
EPS Next Y-114.47%
EPS Next 2Y-1.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-81.67%
Revenue Next 2Y-27.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACON Yearly Revenue VS EstimatesACON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 100K 200K 300K
ACON Yearly EPS VS EstimatesACON Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -10 -20 -30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ACON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ACON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACON Price Earnings VS Forward Price EarningsACON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACON Per share dataACON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.95%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ACON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACLARION INC

NASDAQ:ACON (1/21/2025, 8:00:00 PM)

Premarket: 0.044 +0 (+3.53%)

0.0425

+0 (+0.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-14 2024-11-14/dmh
Earnings (Next)N/A N/A
Inst Owners3.28%
Inst Owner Change0%
Ins Owners10.11%
Ins Owner Change0%
Market Cap443.70K
Analysts80
Price Target1.33 (3029.41%)
Short Float %17.57%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.46%
Min EPS beat(2)22.6%
Max EPS beat(2)24.32%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-51.26%
Min Revenue beat(2)-56.98%
Max Revenue beat(2)-45.53%
Revenue beat(4)0
Avg Revenue beat(4)-67.13%
Min Revenue beat(4)-90.98%
Max Revenue beat(4)-45.53%
Revenue beat(8)2
Avg Revenue beat(8)-36.71%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4%
PT rev (3m)4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)6.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.22
P/FCF N/A
P/OCF N/A
P/B 0.27
P/tB 1.09
EV/EBITDA N/A
EPS(TTM)-4.73
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS0.01
BVpS0.16
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -191.03%
ROE -359.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-257.22%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 117.61%
Cap/Sales 378.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 1.28
Altman-Z -26.38
F-Score4
WACC8.57%
ROIC/WACCN/A
Cap/Depr(3y)91.21%
Cap/Depr(5y)N/A
Cap/Sales(3y)224.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.79%
EPS Next Y-114.47%
EPS Next 2Y-1.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.17%
Revenue growth 3Y15.77%
Revenue growth 5YN/A
Sales Q2Q%-35.74%
Revenue Next Year-81.67%
Revenue Next 2Y-27.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.31%
OCF growth 3YN/A
OCF growth 5YN/A